Fuse Medical, Inc. appointed Mark W. Brooks, the company's Chairman of the Board, to the position of President. The board appointed Christopher C. Reeg, the company's Chief Executive Officer and a member of the Board, to the position of Secretary. The Board appointed William E. McLaughlin, III, the company's Interim Chief Financial Officer and a member of the Board, to the position of Chief Financial Officer and Treasurer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.082 USD | -13.63% | -13.58% | -28.61% |
2023 | Earnings Flash (FZMD) FUSE MEDIAL Reports Q2 Revenue $5M | MT |
2023 | Fuse Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-28.61% | 5.77M | |
-4.98% | 182B | |
+2.84% | 112B | |
-2.68% | 68.58B | |
+4.53% | 51.58B | |
+8.00% | 44.24B | |
+9.45% | 43.65B | |
+25.30% | 32.46B | |
+20.94% | 25.99B | |
-0.17% | 25.61B |
- Stock Market
- Equities
- FZMD Stock
- News Fuse Medical, Inc.
- Fuse Medical, Inc. Announces Management Changes